ASCO and the National Cancer Institute: Strategic Initiatives in Clinical Research

Special Session on Strategic Initiatives in Clinical Research

Saturday, May 14, 2005
9:30 a.m. - 10:45 a.m.
Level 4, Valencia Room, 415B

Moderator: Robert F. Ozols, MD, PhD
Senior Vice President, Medical Science, Fox Chase Cancer Center

Speakers:

James H. Doroshow, M.D.
Chairman, NCI Clinical Trials Working Group
Director, NCI Division of Cancer Treatment and Diagnosis

Howard A. Fine, M.D.
Co-Chairman, NCI Clinical Trials Working Group
Chief, Neuro-Oncology Branch, NCI Center for Cancer Research

David R. Parkinson, M.D.
Vice President and Head, Clinical Oncology Therapeutic Area, Amgen

Andrew C. von Eschenbach, M.D.
Director
National Cancer Institute

David H. Johnson, M.D.
Director, Division of Hematology/Oncology
Deputy Director, Vanderbilt Ingram Cancer Center, Vanderbilt University

Richard L. Schilsky, M.D.
Professor of Medicine
Associate Dean for Clinical Research, University of Chicago
Chairman, CALGB